Targeting of HSF1 as a therapeutic approach to inhibit the progression of hormone-dependent breast cancer.
2021/43/B/NZ5/01850
Keywords
Descriptors
- NZ5_003: Patogeneza chorób człowieka
- NZ5_007: Leczenie chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 8
Call
OPUS 22 – announced on 2021-09-15
- Amount awarded
- 1 218 780 PLN
- Project start date
- 2022-06-27
- Project end date
- 2027-01-26
- Project duration
- 55 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
An Increase in HSF1 Expression Directs Human Mammary Epithelial Cells toward a Mesenchymal Phenotype
- Authors:
- Natalia Vydra, Agnieszka Toma-Jonik, Patryk Janus, Katarzyna Mrowiec, Tomasz Stokowy, Magdalena Głowala-Kosińska, Damian Robert Sojka, Magdalena Olbryt, Wiesława Widłak
- Academic press:
- Cancers (Basel) (year: 2023, volume: 15, pages: 4965), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/cancers15204965 – link to the publication